Company Directory

Full service clinical trial and real-world evidence study management

O4 Research is a Belfast-based clinical research and site management organisation delivering full service and functional clinical trial services to pharmaceutical, biotechnology and consumer health companies across the UK, Ireland and Europe. The company specialises in late-phase clinical trials and non-interventional real-world evidence studies, offering services spanning concept development, study design, patient recruitment, clinical monitoring, regulatory submissions, medical writing, and data management.

Specialist oncology clinical trial management for biotech and pharma

Karma Oncology is a specialist contract research organisation providing full-service and functional clinical trial management to biotechnology and pharmaceutical companies in oncology. Operating as a lean virtual CRO, the company offers clinical development planning, protocol design, site selection and activation, regulatory submissions, patient recruitment, and clinical monitoring. The team has experience across solid tumours, haematological malignancies, checkpoint inhibitors, and cell therapy programmes including CAR-T.

Clinical trial site management and patient recruitment services

4 Medical Clinical Solutions (4MCS) is a UK-based clinical research organisation providing dedicated clinical trial site and patient recruitment services for pharmaceutical and medical research studies. The company supports Phase Ib to Phase IV clinical trials through site management, feasibility assessment and access to patient populations across multiple therapeutic areas. 4MCS works with pharmaceutical and research partners to deliver clinical studies and real-world evidence generation from its research facilities in the UK.

Cell and gene therapy supply chain orchestration software

TrakCel is a Welsh software company providing digital orchestration platforms for the management, tracking, and control of cell and gene therapy products across clinical and commercial supply chains. Its flagship platform manages chain of identity and chain of custody for personalised therapies from sample collection through manufacturing to patient administration, supporting compliance, quality, and traceability requirements. TrakCel serves therapy developers, manufacturers, and authorised treatment centres globally.

Full-service CRO for pharmaceutical and biotech clinical trials

Acceler8 Clinical Research is a contract research organisation providing clinical trial management and support services to pharmaceutical, biotechnology, and medical device companies. Services span clinical development, data management, regulatory affairs, clinical quality assurance, and project management across multiple therapeutic areas including oncology, neurology, cell and gene therapy, and rare disease. The company operates as a trading name of The Pharmaceutical Code Company Limited, a subsidiary of Arithmos.

Specialist CRO for oncology, rare disease, and neurology clinical trials

Evestia Clinical is a global specialist contract research organisation providing full-service and functional clinical trial support to biotech and pharmaceutical companies. The company offers clinical operations, site and project management, regulatory affairs, biostatistics, pharmacovigilance, and medical writing across oncology, rare disease, neurology, and immunology. Backed by Kester Capital and headquartered in Letchworth, Evestia Clinical serves clients from early phase through to post-marketing studies.

Decentralised clinical trial site bringing research to participants

The Virtual Clinical Trial Centre is a clinical research organisation operating a network of flexible, patient-centric trial sites across the UK and Spain. Its decentralised model allows participants to engage in clinical research from home or local sites, addressing the geographic and logistical barriers that limit recruitment and retention in conventional trials. Services include end-to-end trial management, patient recruitment, trial design consultancy, and regulatory support across several therapeutic areas.